Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac Yi Kim

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Plos One|January 5, 2011
Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancerWon Tae Kim, Seok Joong Yun, Cheol Park, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 24, 2011
Impact of robot-assisted radical prostatectomy on health-related quality of life in patients with lower urinary tract symptomsEun Yong Choi, Jeongyun Jeong, Dong Il Kang, et al.
Cancer Research|July 5, 2002
Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathwayIsaac Yi Kim, Do Hwan Seong, Byung-Chul Kim, et al.
Molecular Cancer Therapeutics|December 5, 2020
Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen TherapyGeun Taek Lee, Naoya Nagaya, Jenny Desantis, et al.
Journal of Korean Medical Science|September 28, 2011
Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levelsWon Tae Kim, Seok Joong Yun, Young Deuk Choi, et al.
British Journal of Cancer|January 31, 2018
WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophagesGeun Taek Lee, Seok Joo Kwon, Jongmyung Kim, et al.
Cancer Research|October 20, 2004
Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1Isaac Yi Kim, Dong-Hyeon Lee, Dug Keun Lee, et al.
BMC Urology|April 9, 2014
Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomyJung Hun Kang, Yun-Sok Ha, Sung Kim, et al.
Journal of Endourology|August 31, 2013
Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomySeung Hyo Woo, Dong Il Kang, Yun-Sok Ha, et al.
The World Journal of Men'S Health|May 10, 2013
Clinical Significance of Wnt/β-Catenin Signalling and Androgen Receptor Expression in Prostate CancerSoo Jin Jung, Sangtaek Oh, Geun Taek Lee, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Plos One|January 5, 2011
Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancerWon Tae Kim, Seok Joong Yun, Cheol Park, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 24, 2011
Impact of robot-assisted radical prostatectomy on health-related quality of life in patients with lower urinary tract symptomsEun Yong Choi, Jeongyun Jeong, Dong Il Kang, et al.
Cancer Research|July 5, 2002
Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathwayIsaac Yi Kim, Do Hwan Seong, Byung-Chul Kim, et al.
Molecular Cancer Therapeutics|December 5, 2020
Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen TherapyGeun Taek Lee, Naoya Nagaya, Jenny Desantis, et al.
Journal of Korean Medical Science|September 28, 2011
Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levelsWon Tae Kim, Seok Joong Yun, Young Deuk Choi, et al.
British Journal of Cancer|January 31, 2018
WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophagesGeun Taek Lee, Seok Joo Kwon, Jongmyung Kim, et al.
Cancer Research|October 20, 2004
Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1Isaac Yi Kim, Dong-Hyeon Lee, Dug Keun Lee, et al.
BMC Urology|April 9, 2014
Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomyJung Hun Kang, Yun-Sok Ha, Sung Kim, et al.
Journal of Endourology|August 31, 2013
Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomySeung Hyo Woo, Dong Il Kang, Yun-Sok Ha, et al.
The World Journal of Men'S Health|May 10, 2013
Clinical Significance of Wnt/β-Catenin Signalling and Androgen Receptor Expression in Prostate CancerSoo Jin Jung, Sangtaek Oh, Geun Taek Lee, et al.
Pageof 15